Key points are not available for this paper at this time.
Lung adenocarcinoma (LUAD) has been observed to have significant sex differences in incidence, prognosis, and response to therapy. However, the molecular mechanisms responsible for these disparities have not been investigated extensively.
Saha et al. (Tue,) studied this question.